<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
   <channel>
      <title>Alta Partners</title>
      <link>http://www.altapartners.com/</link>
      <description>Alta Partners news.</description>
      <language>en</language>
      <copyright>Copyright 2006</copyright>
      <lastBuildDate>Fri, 02 May 2008 00:00:00 +0800</lastBuildDate>
      <generator>http://www.php.net/</generator>
      <docs>http://blogs.law.harvard.edu/tech/rss</docs> 
        
            <item>
         <title><![CDATA[OPAL - New Immune Treatment May Control AIDS Virus
]]></title>
         <description><![CDATA[
    <p><a href='http://www.reuters.com/article/healthNews/idUSN0231211820080502?feedType=RSS&feedName=healthNews&rpc=22&sp=true'>http://www.reuters.com/article/healthNews/idUSN0231211820080502?feedType=RSS&feedName=healthNews&rpc=22&sp=true</a></p> 
        ]]></description>
         <link>http://www.reuters.com/article/healthNews/idUSN0231211820080502?feedType=RSS&amp;feedName=healthNews&amp;rpc=22&amp;sp=true</link>
         <guid>http://www.reuters.com/article/healthNews/idUSN0231211820080502?feedType=RSS&amp;feedName=healthNews&amp;rpc=22&amp;sp=true</guid>
         <pubDate>Fri, 02 May 2008 00:00:00 +0800</pubDate>
      </item>
        
            <item>
         <title><![CDATA[For Lipitor King, It’s Deja Vu All Over Again - Esperion Therapeutics]]></title>
         <description><![CDATA[
    <p>Source: Wall Street Journal</p>
<p><a href=' http://blogs.wsj.com/health/2008/05/01/for-lipitor-king-its-deja-vu-all-over-again/?mod=WSJBlog/trackback/'> http://blogs.wsj.com/health/2008/05/01/for-lipitor-king-its-deja-vu-all-over-again/?mod=WSJBlog/trackback/</a></p> 
        ]]></description>
         <link> http://blogs.wsj.com/health/2008/05/01/for-lipitor-king-its-deja-vu-all-over-again/?mod=WSJBlog/trackback/</link>
         <guid> http://blogs.wsj.com/health/2008/05/01/for-lipitor-king-its-deja-vu-all-over-again/?mod=WSJBlog/trackback/</guid>
         <pubDate>Thu, 01 May 2008 00:00:00 +0800</pubDate>
      </item>
        
            <item>
         <title><![CDATA[Esperion Therapeutics Completes $22.75 M Series A Financing]]></title>
         <description><![CDATA[
    <p>Pfizer Inc Spinout of Esperion Therapeutics - Founding Team to Focus on HDL Therapies As a Private Entity</p>
<p><a href='http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp?rssUrl=http://mediaroom.pfizer.com/portal/site/pfizer/index.jsp?ndmViewId=news_view&ndmConfigId=1010794&newsId=20080501005628&newsLang=en'>http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp?rssUrl=http://mediaroom.pfizer.com/portal/site/pfizer/index.jsp?ndmViewId=news_view&ndmConfigId=1010794&newsId=20080501005628&newsLang=en</a></p> 
        ]]></description>
         <link>http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp?rssUrl=http://mediaroom.pfizer.com/portal/site/pfizer/index.jsp?ndmViewId=news_view&amp;ndmConfigId=1010794&amp;newsId=20080501005628&amp;newsLang=en</link>
         <guid>http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp?rssUrl=http://mediaroom.pfizer.com/portal/site/pfizer/index.jsp?ndmViewId=news_view&amp;ndmConfigId=1010794&amp;newsId=20080501005628&amp;newsLang=en</guid>
         <pubDate>Thu, 01 May 2008 00:00:00 +0800</pubDate>
      </item>
        
            <item>
         <title><![CDATA[Aegis Lightwave Acquires CardinalPoint Optics]]></title>
         <description><![CDATA[
    <p><a href='http://www.aegislightwave.com/news_press_releases.html'>http://www.aegislightwave.com/news_press_releases.html</a></p> 
        ]]></description>
         <link>http://www.aegislightwave.com/news_press_releases.html</link>
         <guid>http://www.aegislightwave.com/news_press_releases.html</guid>
         <pubDate>Wed, 23 Apr 2008 00:00:00 +0800</pubDate>
      </item>
        
            <item>
         <title><![CDATA[Investors Remain Cautious]]></title>
         <description><![CDATA[
    <p>Source: Philadelphia Inquirer</p>
By Linda Lloyd <br /> 
Staff Writer                 
<br /><br />
Monday, April 21, 2008
<br /><br />
The slowing economy is taking a toll on venture-capital spending for young start-up companies, according to a quarterly survey. 
<br /><br />
Venture capitalists were more cautious in the first quarter this year, investing $7.1 billion nationally in 922 deals. That was down 8.5 percent from the fourth quarter, when $7.8 billion was invested in 1,045 deals. 
<br /><br />
In the ... 
        ]]></description>
         <link>http://www.altapartners.com/news_detail.php?id=294</link>
         <guid>http://www.altapartners.com/news_detail.php?id=294</guid>
         <pubDate>Mon, 21 Apr 2008 00:00:00 +0800</pubDate>
      </item>
 
  </channel>
</rss>
     